| 1 | Azd4017 and prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0751件: 75 💬 | 
| 2 | Combination therapy with vigabatrin and prednisolone | Prednisolone | 9件: D00472D00472, D00535D00535, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | ABAT2件: ABAT, NR3C1 💬 | Alanine, aspartate and glutamate metabolism8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism | 1451件: 145 💬 | 
| 3 | Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | Acetate | 21件: D00088D00088, D00292D00292, D00472D00472, D00473D00473, D00973D00973, D00975D00975, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01510D01510, D01615D01615, D01632D01632, D01948D01948, D01998D01998, D02156D02156, D02174D02174, D02591D02591, D02592D02592, D03301D03301, D07749D07749 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0811件: 81 💬 | 
| 4 | Corticosteroid (prednisolone) | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0851件: 85 💬 | 
| 5 | Corticosteroid treatment (methylprednisolone or prednisolone) | Methylprednisolone | 14件: D00407D00407, D00472D00472, D00751D00751, D00979D00979, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301, D05000D05000, D05001D05001, D05002D05002 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0641件: 64 💬 | 
| 6 | Corticosteroids (prednisone or prednisolone) | Prednisolone | 9件: D00472D00472, D00473D00473, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0491件: 49 💬 | 
| 7 | Etanercept, methotrexate, prednisolone | Etanercept | 11件: D00142D00142, D00472D00472, D00742D00742, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02115D02115, D02156D02156, D03301D03301 💬 | DHFR5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 | AGE-RAGE signaling pathway in diabetic complications70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway | 0561件: 56 💬 | 
| 8 | Glucocorticoid (prednisone or prednisolone) | Prednisolone | 9件: D00472D00472, D00473D00473, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0841件: 84 💬 | 
| 9 | Intravenous methyl prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0431件: 43 💬 | 
| 10 | Lodotra (delayed release prednisolone) | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0411件: 41 💬 | 
| 11 | Long-circulating liposomal prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 12 | Low dose prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0841件: 84 💬 | 
| 13 | Medium dose prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0841件: 84 💬 | 
| 14 | Methotrexate - etanercept - prednisolone arm | Etanercept | 11件: D00142D00142, D00472D00472, D00742D00742, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02115D02115, D02156D02156, D03301D03301 💬 | DHFR5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 | AGE-RAGE signaling pathway in diabetic complications70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway | 0461件: 46 💬 | 
| 15 | Methyl prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0433件: 43, 49, 96 💬 | 
| 16 | Methylprednisolone or prednisolone | Methylprednisolone | 14件: D00407D00407, D00472D00472, D00751D00751, D00979D00979, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301, D05000D05000, D05001D05001, D05002D05002 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0651件: 65 💬 | 
| 17 | Oral prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0492件: 49, 145 💬 | 
| 18 | Overencapsulated prednisolone tablets | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 19 | Paroxetine & prednisolone | Paroxetine | 12件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D02260D02260, D02362D02362, D03301D03301, D05374D05374, D05375D05375 💬 | NR3C12件: NR3C1, SLC6A4 💬 | Neuroactive ligand-receptor interaction3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle | 0461件: 46 💬 | 
| 20 | Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp | Paroxetine | 12件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D02260D02260, D02362D02362, D03301D03301, D05374D05374, D05375D05375 💬 | NR3C12件: NR3C1, SLC6A4 💬 | Neuroactive ligand-receptor interaction3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle | 0461件: 46 💬 | 
| 21 | Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp | Paroxetine | 12件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D02260D02260, D02362D02362, D03301D03301, D05374D05374, D05375D05375 💬 | NR3C12件: NR3C1, SLC6A4 💬 | Neuroactive ligand-receptor interaction3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle | 0461件: 46 💬 | 
| 22 | Peg-liposomal prednisolone sodium phosphate | Phosphate ion | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0132件: 13, 97 💬 | 
| 23 | Prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 01140件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 | 
| 24 | Prednisolone & dipyridamole | Dipyridamole | 9件: D00302D00302, D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C13件: NR3C1, PDE4A, PDE5A 💬 | Metabolic pathways7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway | 0461件: 46 💬 | 
| 25 | Prednisolone + mabthera | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0611件: 61 💬 | 
| 26 | Prednisolone 1mg tablets | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0811件: 81 💬 | 
| 27 | Prednisolone 2,5 mg tablets | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0811件: 81 💬 | 
| 28 | Prednisolone 20 mg | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 29 | Prednisolone 40 mg | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 30 | Prednisolone 5 mg | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0462件: 46, 51 💬 | 
| 31 | Prednisolone 5 mg jenapharm | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0411件: 41 💬 | 
| 32 | Prednisolone 5 mg tablets | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0811件: 81 💬 | 
| 33 | Prednisolone 5mg gastro-resistant tablets | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0511件: 51 💬 | 
| 34 | Prednisolone 5mg tablet | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0811件: 81 💬 | 
| 35 | Prednisolone acetate | Acetate | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 2221件: 222 💬 | 
| 36 | Prednisolone and chlorambucil | Chlorambucil | 9件: D00266D00266, D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 2221件: 222 💬 | 
| 37 | Prednisolone and mycophenolate mofetil | Mycophenolate mofetil | 12件: D00472D00472, D00752D00752, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301, D05094D05094, D05095D05095, D05096D05096 💬 | IMPDH13件: IMPDH1, IMPDH2, NR3C1 💬 | Drug metabolism - other enzymes4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism | 2221件: 222 💬 | 
| 38 | Prednisolone and taper | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0511件: 51 💬 | 
| 39 | Prednisolone labesfal | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 40 | Prednisolone sodium metasulphobenzoate | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0971件: 97 💬 | 
| 41 | Prednisolone sodium phosphate | Phosphate ion | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0132件: 13, 97 💬 | 
| 42 | Prednisolone sodium succinate | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0951件: 95 💬 | 
| 43 | Prednisolone tablets b.p. 5mg | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0971件: 97 💬 | 
| 44 | Prednisolone tablets bp | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 45 | Prednisolone tablets bp 1 mg | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 46 | Prednisolone tablets usp 5 mg | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 47 | Prednisolone-dipyridamole | Dipyridamole | 9件: D00302D00302, D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C13件: NR3C1, PDE4A, PDE5A 💬 | Metabolic pathways7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway | 0461件: 46 💬 | 
| 48 | Prednisolone/prednisone | Prednisolone | 9件: D00472D00472, D00473D00473, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0491件: 49 💬 | 
| 49 | Prednisone or prednisolone | Prednisolone | 9件: D00472D00472, D00473D00473, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0661件: 66 💬 | 
| 50 | Prednisone/prednisolone | Prednisolone | 9件: D00472D00472, D00473D00473, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0351件: 35 💬 | 
| 51 | Pyridoxine plus prednisolone | Prednisolone | 10件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D02179D02179, D03301D03301, D08454D08454 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 1451件: 145 💬 | 
| 52 | Soluble prednisolone tablets | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 1451件: 145 💬 | 
| 53 | Sulphasalazine + hydroxychloroquine or prednisolone | Hydroxychloroquine | 9件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301, D08050D08050 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 54 | Trexan+salazopyrin+oxiklorin+prednisolone | Prednisolone | 8件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C11件: NR3C1 💬 | Neuroactive ligand-receptor interaction1件: Neuroactive ligand-receptor interaction | 0461件: 46 💬 | 
| 55 | Trexan+salazopyrin+oxiklorin+prednisolone + infliximab | Infliximab | 9件: D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D02598D02598, D03301D03301 💬 | NR3C12件: NR3C1, TNF 💬 | AGE-RAGE signaling pathway in diabetic complications66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway | 0461件: 46 💬 | 
| 56 | Z102 (prednisolone and dipyridamole). | Dipyridamole | 9件: D00302D00302, D00472D00472, D00980D00980, D00981D00981, D00982D00982, D01239D01239, D01998D01998, D02156D02156, D03301D03301 💬 | NR3C13件: NR3C1, PDE4A, PDE5A 💬 | Metabolic pathways7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway | 0461件: 46 💬 |